Drug Database
DI

diphtheria +tetanus + acellular pertussis + polio + haemophilus influnzae type B vaccine (KD370 / KD 370 / Quintovac)

✓ Approved

Meiji Holdings · 疫苗 · 疫苗

什么是 diphtheria +tetanus + acellular pertussis + polio + haemophilus influnzae type B vaccine?

diphtheria +tetanus + acellular pertussis + polio + haemophilus influnzae type B vaccine 是一种疫苗,由Meiji Holdings研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intramuscular (IM) Injection。

药物档案

商品名KD370, KD 370, Quintovac
公司Meiji Holdings
药物类别疫苗
给药途径Injectable (Others), Intramuscular (IM) Injection
状态Approved

治疗适应症

diphtheria +tetanus + acellular pertussis + polio + haemophilus influnzae type B vaccine 针对 4 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsDiphtheria✓ Approved
Infections and infestationsPertussis✓ Approved
Infections and infestationsTetanus✓ Approved
Surgical and medical proceduresPolio immunisation✓ Approved

相关研究文献

PubMedResearch square2026-11-20

Rethinking the Immune Responses Induced by Commercial Multicomponent Acellular and Whole Cell Pertussis Vaccines and Pertussis Infection in the Baboon Model.

Wang Yihui Y, Villeda Jonatan Maldonado JM, Merkel Tod T

Following the replacement of whole cell pertussis (wP) vaccines with acellular pertussis (aP) vaccines, high-income countries recorded sustained increases in pertussis cases. While aP vaccines protect against severe disease, they fail to prevent colonization and transmission, unlike wP vaccination and natural infection. The mechanisms underlying these differences remain incompletely understood. Trivalent aP vaccines are often characterized as inducing Th2 biased responses due to alum adjuvant. However, most current formulations of aP are combination vaccines containing additional antigens, which may shape the overall immune environment and influence responses to pertussis antigens. To investigate these differences, we profiled immune responses in baboons following aP vaccinations, wP vaccinations and infections using complete blood counts, transcriptomics, and immunological assays. Weighted gene co-expression network analysis revealed fundamental differences in immune polarization. These findings define divergent immune landscapes induced by these three exposures, providing mechanistic insight into their differential protective efficacy and highlighting the importance of vaccine composition in shaping immune responses. Notably, our data suggest that pentavalent aP vaccination may induce distinct innate and cellular immune responses compared to trivalent formulations, with important implications for future vaccine design strategies, and design of clinical trials.

PMID 43060381
阅读全文 →
PubMedZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics2026-11-20

[Levels of pertussis toxin-immunoglobulin G and their influencing factors in children aged 0-14 years].

Zhou Xiu-Qin XQ, Yang Chao-Yan CY, Zhong Xiao-Qun XQ

To investigate the levels and age distribution of pertussis toxin-immunoglobulin G (PT‑IgG) in children aged 0-14 years and to analyze the effects of vaccination history, residential area, and other factors on PT‑IgG levels. A cross-sectional study was designed, in which 1 247 children who attended Luzhou People's Hospital for vaccination from June 2024 to December 2025 were enrolled. Sociodemographic information and diphtheria-tetanus-pertussis vaccination history were collected. Serum PT‑IgG levels were measured (≥40 IU/mL was defined as positive). PT‑IgG positivity rates and levels were compared among groups stratified by age, sex, vaccination history, and residential area. The age-related trend in the PT‑IgG positivity rate and the factors influencing PT‑IgG levels were analyzed. Among the 1 247 children, 896 were seropositive for PT‑IgG, with an overall positivity rate of 71.85%; the geometric mean concentration (GMC) was 68.37 IU/mL (95%CI: 64.12-72.89). The PT‑IgG positivity rate showed a downward trend with increasing age (P<0.05): 92.6% (GMC 125.46 IU/mL) in children aged 0-2 years, 75.9% (GMC 72.18 IU/mL) in those aged >2-7 years, and 62.5% (GMC 45.29 IU/mL) in those aged >7-14 years. The positivity rate was higher in children with complete vaccination (≥4 doses) [78.1% (GMC 75.83 IU/mL)] than in those with incomplete vaccination [17.5% (GMC 36.94 IU/mL)] (P<0.05). Multiple linear regression analysis showed that increasing age, receiving fewer than 3 doses of vaccination, and residing in rural areas were independent risk factors for lower PT-IgG levels (P<0.05). The positivity rate decreased to 53.9% in children ≥ 5 years after the last vaccination. PT‑IgG levels in children decline progressively with age, and school-aged children aged >7-14 years are an immunologically vulnerable population.

PMID 43059339
阅读全文 →
PubMedbioRxiv : the preprint server for biology2026-11-20

Deep phenomics of African green monkey and Baboon PBMCs using a 30-marker spectral flow cytometry panel.

Barman Soumik S, Patel Arsh A, Buonopane Michael J MJ, Janoschek Ben B et al.

Vaccines are the best way to prevent and combat diseases. Non-human primate (NHP) models have proven to be the gold standard model for studying the efficacy of certain vaccine candidates prior to human trials. Cell-mediated immunity serves as a surrogate marker for predicting vaccine efficacy. Despite the availability of deep-immunophenotyping panels for T cells in the peripheral blood of humans, their application to NHPs, particularly African Green Monkeys (AGMs) and baboons, remains limited. Notably, AGMs are valuable for HIV and COVID-19 research, while baboons are utilized for pertussis research as a natural infection model and vaccine trial. To overcome such limitation, using spectral flow cytometry, we developed a 30-parameter panel to profile major immune cell subsets (B cells, NK cells, DCs, monocytes) either in AGM or baboon PBMCs. We also profiled T cells, memory phenotypes, functional cytokines by tracking established Th1 markers IFNγ, TNF and IL-2; Th2 markers IL-4/5/13 and the Th17 marker, IL-17, activation-induced markers (AIMs) and FoxP3 + Tregs in both AGM and baboon PBMCs in steady state as well as in mitogen stimulated conditions. For AIMs, CD69, CD134 (OX40) and CD137 (4-1BB) are included and validated in both NHP species. This panel holds potential for exploratory analysis of the impact of these functional cytokines, AIMs, or Tregs on host immunity following infection or vaccination. The panel's high level of customization empowers researchers to tailor it to their specific research needs.

PMID 43060088
阅读全文 →
PubMedJournal of health, population, and nutrition2026-11-20

A key to combating pertussis through maternal immunization in the Eastern Mediterranean Region: recommended action points from the Expert Network Meeting (ENM) on pertussis maternal immunization.

Haddad Nadine N, Munoz Flor F, Mohseni Ezzeddine E, Ulloa-Gutierrez Rolando R et al.

Pertussis can seriously affect infants who are too young to be fully immunized (< 6 months of age) leading to increased risk of severe and potentially lethal complications. Pertussis control remains fragile in EMR, facing several challenges from the healthcare sector and providers, likewise low awareness, and a lack of clear recommendation of maternal immunization and maternal care services for infectious disease prevention and treatment, particularly against pertussis. The Eastern Mediterranean Public Health Network (EMPHNET) launched the initiative entitled "The Way Forward for Pertussis Control in EMR: Focus on Maternal Immunization" aims to emphasize that the primary goal is the control of pertussis, initially focusing on the protection of infants under 4 months through maternal vaccination strategies. This initiative aimed to leverage existing epidemiological data and disease burden, as well as the exchange of successful experiences both regionally and globally related to maternal vaccination strategies. The following document presents the key findings of the Expert Network Meeting on Pertussis Control implemented in Amman-Jordan in 4-8 August 2024. It proposes the way forward for Pertussis control strategies in the EMR, with recommendations on bolstering regional efforts towards strengthening maternal Tdap immunization.

PMID 43058853
阅读全文 →
PubMedClinical case reports2026-11-20

Clinically Suspected Fulminant Myocarditis Following PCR-Confirmed Pertussis in an Infant: A Case Report.

Isaa Janaa J, Fasfoos Ahmad A, Hmidat Fatima F, Hroub Nardeen N et al.

Cardiac involvement following pertussis infection is uncommon but may be associated with severe clinical deterioration in infants. We report the case of a 3-month-old girl who developed shock, ventricular arrhythmias, and severe biventricular systolic dysfunction approximately 2 weeks after PCR-confirmed Bordetella pertussis infection. Echocardiography demonstrated marked left ventricular dilatation, global hypokinesia, and a left ventricular ejection fraction of 28%. Troponin I was markedly elevated. The clinical presentation was consistent with suspected fulminant myocarditis, although definitive myocardial confirmation was unavailable. The infant received intensive supportive care, inotropic treatment, heart failure medications, antiarrhythmic therapy, and intravenous immunoglobulin, with subsequent clinical and echocardiographic improvement. She was discharged in a stable condition but died unexpectedly approximately 2 months later. The immediate cause of death remained undetermined. This case emphasizes the importance of early cardiac assessment and structured post-discharge surveillance in infants with severe cardiac dysfunction following pertussis infection.

PMID 43061697
阅读全文 →
PubMedPreventive medicine reports2026-11-20

Parental hesitancy toward free human papillomavirus vaccination in Taizhou, China.

Chen Jia-Ni JN, Luo Xu X, Chen Si-Jia SJ, Li Yi-Yi YY et al.

Vaccine hesitancy undermines human papillomavirus (HPV) vaccination even under free policies. Integrating the Knowledge-Attitude-Practice framework with the Capability, Opportunity, Motivation, and Behavior (COM-B) model, we aimed to explore how knowledge and attitudes influence parents' hesitancy toward free HPV vaccination. A cross-sectional survey was conducted among 338 parents of middle-school girls in Taizhou, Zhejiang Province, China, form November 15 to December 20, 2025. Knowledge, attitudes, and COM-B dimensions were assessed, and path analysis was used to test the integrated model and mediating effects. Hesitancy was reported in 43.20% of parents. The model showed good fit. More positive attitudes had stronger explanatory power than knowledge (β = -0.368) and reduced hesitancy by enhancing opportunity and trust motivation. Higher trust motivation was the main factor associated with reduced hesitancy, whereas higher risk-perception motivation increased hesitancy. Knowledge dissemination alone is insufficient to reduce hesitancy. Positive attitudes, particularly perceived vaccine effectiveness and safety, play a more critical role then knowledge through COM-B mediators. Interventions must build trust and improve structural opportunities.

PMID 43061700
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多diphtheria +tetanus + acellular pertussis + polio + haemophilus influnzae type B vaccine